Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jillian Clare Kohler

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
International Journal of Health Policy and Management|October 29, 2019
I Know It When I See It: The Challenges of Addressing Corruption in Health Systems Comment on "We Need to Talk About Corruption in Health Systems"Jillian Clare Kohler
Globalization and Health|October 21, 2020
Exploring anti-corruption, transparency, and accountability in the World Health Organization, the United Nations Development Programme, the World Bank Group, and the Global Fund to Fight AIDS, Tuberculosis and MalariaJillian Clare Kohler, Andrea Bowra
Global Health Action|March 21, 2020
The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this riskJillian Clare Kohler, Deirdre Dimancesco
The International Journal of Risk & Safety in Medicine|December 14, 2011
The danger of imperfect regulation: OxyContin use in the United States and CanadaJoel Lexchin, Jillian Clare Kohler
Globalization and Health|March 7, 2025
Corruption risks in COVID-19 vaccine deployment: lessons learned for future pandemic preparednessGul Saeed, Jillian Clare Kohler
Health Law Journal|June 20, 2009
Finding flaws: the limitations of compulsory licensing for improving access to medicines--an international comparisonEmily Ng, Jillian Clare Kohler
Globalization and Health|January 8, 2014
"To patent or not to patent? the case of Novartis' cancer drug Glivec in India"Ravinder Gabble, Jillian Clare Kohler
Journal of Pharmaceutical Policy and Practice|September 16, 2020
The Urgent Need for Transparent and Accountable Procurement of Medicine and Medical Supplies in Times of COVID-19 PandemicJillian Clare Kohler, Tom Wright
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|September 7, 2010
The success rate of new drug development in clinical trials: Crohn's diseaseJayson L Parker, Jillian Clare Kohler
Globalization and Health|April 5, 2012
The politics behind the implementation of the WTO Paragraph 6 Decision in Canada to increase global drug accessLaura C Esmail, Jillian Clare Kohler
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
International Journal of Health Policy and Management|October 29, 2019
I Know It When I See It: The Challenges of Addressing Corruption in Health Systems Comment on "We Need to Talk About Corruption in Health Systems"Jillian Clare Kohler
Globalization and Health|October 21, 2020
Exploring anti-corruption, transparency, and accountability in the World Health Organization, the United Nations Development Programme, the World Bank Group, and the Global Fund to Fight AIDS, Tuberculosis and MalariaJillian Clare Kohler, Andrea Bowra
Global Health Action|March 21, 2020
The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this riskJillian Clare Kohler, Deirdre Dimancesco
The International Journal of Risk & Safety in Medicine|December 14, 2011
The danger of imperfect regulation: OxyContin use in the United States and CanadaJoel Lexchin, Jillian Clare Kohler
Globalization and Health|March 7, 2025
Corruption risks in COVID-19 vaccine deployment: lessons learned for future pandemic preparednessGul Saeed, Jillian Clare Kohler
Health Law Journal|June 20, 2009
Finding flaws: the limitations of compulsory licensing for improving access to medicines--an international comparisonEmily Ng, Jillian Clare Kohler
Globalization and Health|January 8, 2014
"To patent or not to patent? the case of Novartis' cancer drug Glivec in India"Ravinder Gabble, Jillian Clare Kohler
Journal of Pharmaceutical Policy and Practice|September 16, 2020
The Urgent Need for Transparent and Accountable Procurement of Medicine and Medical Supplies in Times of COVID-19 PandemicJillian Clare Kohler, Tom Wright
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|September 7, 2010
The success rate of new drug development in clinical trials: Crohn's diseaseJayson L Parker, Jillian Clare Kohler
Globalization and Health|April 5, 2012
The politics behind the implementation of the WTO Paragraph 6 Decision in Canada to increase global drug accessLaura C Esmail, Jillian Clare Kohler
Pageof 4